SecBot SecBot
COURT-RULING ·Filed May 18, 2026

ABBV

Abbvie
NEUTRAL
Impact 3/10
Horizonimmediate Processed6mo ago CourtCourt Ruling · courtlistener.com
Court ruling (appellate)
Actionable Insight • Neutral

This ruling closes a minor product liability case with no financial impact on AbbVie. No market reaction expected. Monitor for any Illinois Supreme Court appeal petition, though unlikely given the record.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$209.41
T+0 close · May 18, 2026 · via day close
Latest settled
+18.79%
T+60 · $248.76
Vs SPY
+13.94%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 18 $209.41entry
  2. T+1 · 6mo ago +2.08%α +2.73% · $213.76
  3. T+5 · 6mo ago +1.77%α +0.15% · $213.12
  4. T+20 · 5mo ago +6.24%α +4.66% · $222.47
  5. T+60 · 3mo ago +18.79%α +13.94% · $248.76
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

The Illinois Appellate Court affirmed summary judgment for AbbVie in a product liability case over its XEN gel stent. The plaintiff failed to provide expert testimony that a manufacturing defect caused his injuries, ending the litigation in AbbVie's favor.

Court Ruling Details

Ruling Date
May 18, 2026
Court
Appellate Court of Illinois, Third District
Court Level
Appellate
Judge
Justice Brennan
Case Type
product liability
Ruling Type
final judgment
Outcome
WIN: ruling favors this company
Precedent Risk
LOW

Key Facts

  • Appellate court affirmed summary judgment for AbbVie in strict product liability action.
  • Plaintiff alleged XEN gel stent had chemical residue causing eye injuries but lacked expert causation evidence.
  • Non-precedential order under Illinois Supreme Court Rule 23(e)(1).
  • No damages awarded, no injunction, no class action.

Financial Impact

No damages awarded; litigation costs immaterial relative to $371.7B market cap.

Risk Factors

  • Potential plaintiff appeal to Illinois Supreme Court is low probability and would not change outcome without expert evidence.

Market Snapshot

Price
$209.56
Volume
100
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
75% bullish (40 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-3c4wl60q-ABBV

Track record

22 reports on ABBV

Performance horizon

7 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +27.21% at T+60 after the Apr 29, 2026 report. 7 of 9 went positive at some point.

Filters
  1. Nov 9, 20267d ago 144 Neutral 2/10 Entry $293.89 Now $294.55 +0.22% settles Dec 9
  2. Nov 2, 202614d ago 8-K Neutral 2/10 Entry $286.00 Now $294.55 +2.99% settles Dec 2
  3. Oct 30, 202617d ago 8-K Bullish 6/10 Entry $294.89 Now $294.55 −0.12% settles Nov 30
  4. Oct 29, 202619d ago Court Ruling Bullish 7/10 Entry $294.89 Now $294.55 −0.12% settles Nov 30
  5. Oct 16, 20264w ago Institutional Cluster Bullish 4/10 Entry $282.68 to $294.55 Now $294.55 +4.20% ▲ +4.20% +7.66% vs SPY
  6. Oct 15, 20264w ago 8-K Neutral 2/10 Entry $285.42 to $295.03 Now $294.55 +3.20% ▲ +3.37% +4.53% vs SPY
  7. Oct 5, 20266w ago 8-K Neutral 4/10 Entry $265.06 to $289.60 Now $294.55 +11.12% ▲ +9.26% +12.16% vs SPY
  8. Sep 28, 20267w ago Court Ruling Neutral 2/10 Entry $263.29 to $286.39 Now $294.55 +11.87% ▲ +8.77% +8.06% vs SPY
  9. Sep 14, 20269w ago Court Ruling Neutral Not scored Entry $261.43 to $272.69 Now $294.55 +12.67% ▲ +4.30% +1.33% vs SPY
  10. Sep 3, 202610w ago 8-K Neutral 4/10 Entry $260.21 to $262.82 Now $294.55 +13.20% ▲ +1.00% +2.19% vs SPY
Showing 10 of 22

US Market Status

Market Closed · Opens Wed (11h 2m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · courtlistener.com Report published May 18, 2026